|
Table of Contents
Executive Summary
Chapter 1
Report Scope
Thematic Scope
Scope of Data Analysis
Temporal Scope of Analysis
Geographical Scope
Report objective
Methodology
Calculation of CAGR
The Nanoscale
Chapter 2
Overview of nanotechnology
What are the Key Drivers for Adoption of Nanotechnology in Medicine and Biomedicine?
The Key Applications of Nanotechnology in Medicine and Biomedicine
How Nanotechnology Can Benefit Drug Delivery
How Nanotechnology Is Already Having An Impact On The Drug Delivery Sector
Chapter 3
Three Key Barriers to The Adoption of Nanotechnology in Medicine and Biomedicine
Five Current & Future Challenges in The Adoption of Nanotechnology in Medicine and Biomedicine
Chapter 4
Global Market Analysis: 2000-2010 (Without Segmentation)
Global Market Forecast: 2011-2021 (Without Segmentation)
Market Analysis Countries and Regions: 2000-2010 (With Segmentation)
Market Forecast Countries and Regions: 2011-2021 (With Segmentation)
Appendix
Publishing activity by organization (2000-2010)
Table of Exhibits
Chapter One
Exhibit 1.1
- Formula for the calculation of the Compound Annual Growth Rate (CAGR), (top).
- Formula for the calculation of the Compound Annual Growth Rate (CAGR) in this report, for the 2011-2021 period, (bottom) [2].
Exhibit 1.2
- Formula for the verification of the calculated values of the Compound Annual Growth Rate (CAGR), (top).
- Formula for the verification of the calculated values of the Compound Annual Growth Rate (CAGR) in this report, for the 2011-2021 period, (bottom) [2].
Exhibit 1.3
- Nanometres in a meter (top). Meters in a nanometre (bottom).
Chapter Two
Exhibit 2.1
- The periodic table of elements, as we know it (at meter scale) is governed by classic Newtonian laws of physics. However, when perceived at nanoscale, those elements are governed by the laws of quantum physics.
Exhibit 2.2
- Proportion of the population aged over 65 and over 80 [7].
Exhibit 2.3
- Illustration of a diagram of each property of nanocarriers (size, shape, surface chemistry and mechanical properties) and their parameters subjected to optimization in order to improve their efficiency [10].
Chapter Three
Exhibit 3.1
- Specified expected barriers in the development of particular types of nanoparticles (Courtesy of CienNanoroadmap Synthesis Report), [6].
Exhibit 3.2
- Illustration of the measures adoption roadmap to combat/attenuate the key barriers to the adoption of nanotechnology in medicine and biomedicine (Source: Cientifica, Ltd.).
Exhibit 3.3
- Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.4
- Line chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.5
- Bar chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.6
- Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.7
- Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).
Exhibit 3.8
- Bar chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).
Chapter Four
Exhibit 4.8
- Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, all countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.9
- 3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures in percentage).
Exhibit 4.10
- Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.11
- Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.12
- 3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.13
- 3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.14
- 3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, all world regions and countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.15
- Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, all world regions and countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.16
- 3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures in percentage)
Exhibit 4.17
- Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.18
- Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.19
- 3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.20
- 3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.21
- 3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.22
- Horizontal bar graph representing the Total Addressable Market, TAM In 2010, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.23
- Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.24
- 3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.25
- 3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.46
- Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions / countries, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.47
- 3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures in percentage).
Exhibit 4.48
- Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.49
- Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.50
- 3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.51
- 3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.52
- 3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.53
- Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.54
- Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.55
- 3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.56
- 3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.57
- 3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.58
- Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.59
- Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.60
- 3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.61
- 3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.62
- 3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures in percentage).
Exhibit 4.63
- Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.64
- Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.65
- 3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Exhibit 4.66
- 3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).
Appendix
Exhibit A.1
- Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: North America; country: USA.
- Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.2
- Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: Germany.
- Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.3
- Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: France.
- Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.4
- Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: UK.
- Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.5
- Table of publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. Country: Russian Federation.
- Organizations are ordered alphabetically (increasing order).
Exhibit A.6
- Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: India.
- Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.7
- Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: India.
- Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.8
- Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: Japan.
- Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.9
- Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: P R China.
- Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.10
- Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: South Korea (Republic of Korea).
- Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
Exhibit A.11
- Table of publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. Asia; country: Taiwan.
- Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.
|
현재위치 : 
